174
Participants
Start Date
December 12, 2022
Primary Completion Date
February 29, 2028
Study Completion Date
February 29, 2028
Botensilimab
An anti-CTLA-4 monoclonal antibody
Balstilimab
An anti-PD-1 monoclonal antibody
CHUV - Centre hospitalier universitaire vaudois, Lausanne
Universitair Ziekenhuis Brussel, Jette
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Clinic Barcelona, Barcelona
Onkologikoa, Donostia / San Sebastian
Georgetown University Medical Center, Washington D.C.
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
University Hospital Schleswig-Holstein, Kiel
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Centre Eugene Marquis, Rennes
CHU Grenoble-Alpes - Hopital Michallon, La Tronche
Hospital Universitario Virgen Macarena, Seville
CHU de Nantes, Nantes
Universitaetsklinikum Essen, Essen
Consorcio Hospital General Universitario de Valencia, Valencia
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l., Meldola
Azienda Ospedaliero Universitaria Senese, Siena
Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz, Mainz
Centre Leon Berard, Lyon
Universitaetsklinikum Heidelberg, Heidelberg
Universitaetsklinikum Tuebingen, Tübingen
AP-HP Hopital Saint-Louis, Paris
CHU Amiens Picardie - Hopital Sud, Amiens
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli
Klinikum der Universitaet München, München
Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale
Providence Saint John's Health Center, Santa Monica
Virginia K. Crosson Cancer Center at St. Jude Medical Center, Fullerton
Universitaetsklinikum Würzburg, Würzburg
Blokhin National Medical Research Oncology Centre, Moscow
"Branch Office of Hadassah Medical Ltd", Moscow
Moscow City Oncology Hospital #62, Moscow
LLC Medical Services, Saint Petersburg
Clinical Hospital Russian Railways - Medicine, Saint Petersburg
Petrov National Medical Research Center of Oncology, Saint Petersburg
Yale University School of Medicine - Yale Cancer Center, New Haven
Dana-Farber Cancer Institute, Boston
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Oncosite - Centro de Pesquisa Clinica Em Oncologia, Ijuí
Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho, Jaú
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre
INCA II - Instituto Nacional de Cancer Jose Alencar Gomes da Silva, Rio de Janeiro
Hospital Sirio Libanes, São Paulo
Real e Benemerita Associaçao Portuguesa de Beneficencia - A Beneficencia Portuguesa de Sao Paulo, São Paulo
Hospital A.C. Camargo Cancer Center, São Paulo
Gustave Roussy, Villejuif
Universitaetsspital Zuerich, Zurich
Royal Marsden Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Mount Vernon Cancer Centre, Middlesex
Lead Sponsor
Agenus Inc.
INDUSTRY